MDBH logo

MDB Capital Holdings, LLC (MDBH)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

MDB Capital Holdings, LLC (MDBH) trades at $2.95 with AI Score 41/100 (Weak). MDB Capital Holdings, LLC operates as a broker-dealer, focusing on private and public securities offerings. Market cap: 30M, Sector: Financial services.

Last analyzed: Feb 8, 2026
MDB Capital Holdings, LLC operates as a broker-dealer, focusing on private and public securities offerings. The company operates through Broker Dealer & Intellectual Property Service, and Technology Development segments.
41/100 AI Score MCap 30M Vol 2K

MDB Capital Holdings, LLC (MDBH) Financial Services Profile

CEOChristopher A. Marlett
Employees16
HeadquartersAddison, DE, US
IPO Year2023

MDB Capital Holdings offers a unique investment opportunity through its focus on intellectual property-backed ventures and dual business segments in broker-dealer services and technology development, leveraging a high-growth potential model within the financial capital markets, despite its small market capitalization of $0.03 billion.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

MDB Capital Holdings presents a notable research candidate due to its unique focus on intellectual property-backed ventures and its dual business segments. The company's high profit margin of 265.2% suggests strong potential for profitability, despite a negative gross margin of -202.3%. Key value drivers include the successful execution of private and public securities offerings and advancements in its synthetic biology technology development. Upcoming catalysts include potential partnerships and successful commercialization of its technology development segment. Investors may want to evaluate MDBH for its potential to capitalize on the growing demand for specialized financial services in the technology sector.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.03 billion indicates a small-cap company with potential for high growth.
  • P/E ratio of 1.42 suggests the company may be undervalued compared to its earnings.
  • Profit Margin of 265.2% reflects strong profitability despite a negative gross margin.
  • Beta of 1.10 indicates the stock is slightly more volatile than the market.
  • Operates through two segments: Broker Dealer & Intellectual Property Service, and Technology Development, diversifying its revenue streams.

Competitors & Peers

Strengths

  • Specialized expertise in intellectual property-backed ventures.
  • Dual business segments providing diversified revenue streams.
  • High profit margin of 265.2%.
  • Focus on emerging technology companies.

Weaknesses

  • Small market capitalization of $0.03 billion.
  • Negative gross margin of -202.3%.
  • Limited geographic reach.
  • Reliance on capital markets activity.

Catalysts

  • Upcoming: Potential partnerships with technology companies to expand service offerings.
  • Ongoing: Successful execution of private and public securities offerings.
  • Ongoing: Advancements in synthetic biology technology development.
  • Ongoing: Increased demand for specialized financial services in the technology sector.

Risks

  • Potential: Economic downturns impacting capital markets activity.
  • Potential: Regulatory changes affecting broker-dealer operations.
  • Potential: Increased competition from larger financial institutions.
  • Ongoing: Negative gross margin impacting profitability.
  • Ongoing: Small market capitalization limiting access to capital.

Growth Opportunities

  • Expansion of Broker Dealer Services: MDB Capital Holdings can expand its broker-dealer services by targeting emerging technology companies seeking capital. The market for private and public securities offerings is estimated to be worth billions of dollars annually, and MDBH can capture a larger share by offering specialized expertise in intellectual property valuation and structuring deals that attract investors. Timeline: Ongoing.
  • Advancements in Synthetic Biology Technology: The Technology Development segment offers significant growth potential through advancements in synthetic biology. The synthetic biology market is projected to reach $40 billion by 2027, and MDBH can capitalize on this growth by developing innovative technologies and securing strategic partnerships. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: MDB Capital Holdings can pursue strategic partnerships and acquisitions to expand its market reach and enhance its service offerings. Collaborating with other financial institutions and technology companies can create synergies and accelerate growth. Timeline: Ongoing.
  • Geographic Expansion: Expanding its operations beyond its current base in Addison, Texas, can open up new markets and opportunities for MDB Capital Holdings. Targeting regions with strong technology sectors and venture capital activity can drive revenue growth. Timeline: Ongoing.
  • Enhanced Research and Due Diligence Capabilities: Investing in enhanced research and due diligence capabilities can attract more clients and improve the quality of its investment banking services. Providing in-depth analysis and insights into emerging technology companies can differentiate MDBH from its competitors. Timeline: Ongoing.

Opportunities

  • Expansion of broker-dealer services to emerging technology companies.
  • Advancements in synthetic biology technology development.
  • Strategic partnerships and acquisitions.
  • Geographic expansion to new markets.

Threats

  • Intense competition in the financial capital markets industry.
  • Evolving regulatory landscape.
  • Economic downturns impacting capital markets activity.
  • Technological disruptions in the financial sector.

Competitive Advantages

  • Specialized expertise in intellectual property valuation.
  • Dual business segments providing diversified revenue streams.
  • Focus on emerging technology companies and innovative ventures.
  • Proprietary technology in synthetic biology development.

About MDBH

Founded in 1997 and based in Addison, Texas, MDB Capital Holdings, LLC operates as a broker-dealer, primarily focusing on private and public securities offerings. The company has evolved to operate through two distinct segments: Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment functions as a full-service broker-dealer, providing a range of services including conducting private and public securities offerings and offering research services essential for investment banking due diligence. This segment is crucial for identifying and capitalizing on emerging opportunities in the capital markets. The Technology Development segment is dedicated to the synthetic biology technology development business, indicating a forward-looking approach to integrating technological advancements into its operations. MDB Capital Holdings aims to bridge the gap between innovative companies and the capital markets, offering a unique value proposition to both investors and businesses seeking growth opportunities. The company's strategic focus on intellectual property and technology development positions it as a key player in fostering innovation and driving value creation in the financial sector.

What They Do

  • Operates as a broker-dealer.
  • Focuses on private and public securities offerings.
  • Provides research services for investment banking due diligence.
  • Engages in synthetic biology technology development.
  • Connects innovative companies with capital markets.
  • Offers specialized expertise in intellectual property valuation.

Business Model

  • Generates revenue through fees from private and public securities offerings.
  • Earns income from research services provided to investment banking clients.
  • Potentially generates revenue from the commercialization of synthetic biology technologies.
  • Leverages intellectual property assets to create value for investors and companies.

Industry Context

MDB Capital Holdings operates within the financial capital markets industry, which is characterized by intense competition and evolving regulatory landscapes. The industry is currently experiencing growth driven by increased demand for specialized financial services, particularly in the technology and intellectual property sectors. MDB Capital Holdings differentiates itself through its focus on intellectual property-backed ventures and its technology development segment. Competitors like AHG, ARBK, ATMV, BAFN, and ETHM also operate in this space, but MDBH's unique approach to technology development provides a competitive edge.

Key Customers

  • Emerging technology companies seeking capital.
  • Institutional investors looking for high-growth opportunities.
  • Private investors interested in intellectual property-backed ventures.
  • Companies requiring investment banking due diligence services.
AI Confidence: 71% Updated: Feb 8, 2026

Financials

Chart & Info

MDB Capital Holdings, LLC (MDBH) stock price: $2.95 (+0.02, +0.68%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MDBH.

Price Targets

Wall Street price target analysis for MDBH.

MoonshotScore

41/100

What does this score mean?

The MoonshotScore rates MDBH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

What Investors Ask About MDB Capital Holdings, LLC (MDBH)

What does MDB Capital Holdings, LLC Class A common do?

MDB Capital Holdings operates as a broker-dealer, focusing on facilitating private and public securities offerings, particularly for emerging technology companies. The company operates through two segments: Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer segment provides research and due diligence for investment banking, while the Technology Development segment focuses on synthetic biology. MDBH aims to connect innovative companies with capital markets, leveraging its expertise in intellectual property valuation to drive value creation for both investors and businesses.

Is MDBH stock worth researching?

MDBH presents a speculative investment opportunity with high potential and significant risks. Its high profit margin of 265.2% is attractive, but the negative gross margin of -202.3% raises concerns. The company's focus on intellectual property-backed ventures and technology development provides unique growth catalysts. However, its small market capitalization of $0.03 billion and beta of 1.10 indicate volatility. Investors should carefully consider their risk tolerance and conduct thorough due diligence before investing in MDBH.

What are the main risks for MDBH?

MDBH faces several key risks, including its small market capitalization, which limits access to capital and increases volatility. The negative gross margin poses a significant challenge to profitability. The company operates in a highly competitive and regulated industry, subject to economic downturns and technological disruptions. Its reliance on capital markets activity makes it vulnerable to market fluctuations. Additionally, the success of its Technology Development segment is uncertain and depends on advancements in synthetic biology.

What are the key factors to evaluate for MDBH?

MDB Capital Holdings, LLC (MDBH) currently holds an AI score of 41/100, indicating low score. The stock trades at a P/E of 1.3x, below the S&P 500 average (~20-25x), potentially signaling value. Key strength: Specialized expertise in intellectual property-backed ventures.. Primary risk to monitor: Potential: Economic downturns impacting capital markets activity.. This is not financial advice.

How frequently does MDBH data refresh on this page?

MDBH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven MDBH's recent stock price performance?

Recent price movement in MDB Capital Holdings, LLC (MDBH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized expertise in intellectual property-backed ventures.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider MDBH overvalued or undervalued right now?

Determining whether MDB Capital Holdings, LLC (MDBH) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 1.3. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying MDBH?

Before investing in MDB Capital Holdings, LLC (MDBH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Financial data may be outdated.
  • Forward-looking statements involve risks and uncertainties.
Data Sources

Popular Stocks